Biocon

Biocon Limited is an Indian multinational biopharmaceutical company headquartered in Bangalore, India. It is engaged in the research, development, manufacturing, and marketing of a wide range of biopharmaceuticals, including insulin, biosimilars, and other therapeutic proteins. Biocon's operations span across various therapeutic areas, including diabetes, oncology, immunology, and cardiovascular diseases. The company operates globally, with a significant presence in India, and exports its products to numerous countries worldwide. It has a strong focus on affordable healthcare solutions and innovation in biotechnology, striving to address unmet medical needs through its research and development endeavors. Biocon has a diversified portfolio which includes both branded formulations and generic drugs, catering to a wide range of patients and markets. The company has made significant investments in research and manufacturing infrastructure, establishing state-of-the-art facilities compliant with international standards. Biocon's commitment to quality and regulatory compliance is a cornerstone of its operations, ensuring that its products meet the highest standards of safety and efficacy.